Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
Caron A Jacobson, Jason R Westin, David B Miklos, et al.
Circulation. Arrhythmia and Electrophysiology
|
August 13, 2016
Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks
Nieves Gomez-Hurtado, Nicole J Boczek, Dmytro O Kryshtal, et al.
Human Vaccines & Immunotherapeutics
|
August 27, 2015
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats
Jessica J O'Konek, Paul E Makidon, Jeffrey J Landers, et al.
Ophthalmology
|
May 20, 2018
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings
Tien Y Wong, Jennifer Sun, Ryo Kawasaki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 3, 2017
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
Pilar de la Puente, Micah J Luderer, Cinzia Federico, et al.
Journal of Translational Medicine
|
March 6, 2026
Novel driver gene MDC1 confers homologous recombination repair deficiency and genomic instability in chemoresistant relapsing ovarian cancer
Michael Diaz, Nicole Gull, Pei-Chen Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Leukemia
|
August 30, 2024
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma
Jennifer Sun, Stefan Corradini, Feda Azab, et al.
Nature Communications
|
November 28, 2020
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
Cinzia Federico, Kinan Alhallak, Jennifer Sun, et al.
Nature Genetics
|
January 9, 2023
Single-cell transcriptomic analysis of endometriosis
Marcos A S Fonseca, Marcela Haro, Kelly N Wright, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 Trial
Caron A Jacobson, Jason R Westin, David B Miklos, et al.
Circulation. Arrhythmia and Electrophysiology
|
August 13, 2016
Novel CPVT-Associated Calmodulin Mutation in CALM3 (CALM3-A103V) Activates Arrhythmogenic Ca Waves and Sparks
Nieves Gomez-Hurtado, Nicole J Boczek, Dmytro O Kryshtal, et al.
Human Vaccines & Immunotherapeutics
|
August 27, 2015
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats
Jessica J O'Konek, Paul E Makidon, Jeffrey J Landers, et al.
Ophthalmology
|
May 20, 2018
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings
Tien Y Wong, Jennifer Sun, Ryo Kawasaki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 3, 2017
Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
Pilar de la Puente, Micah J Luderer, Cinzia Federico, et al.
Journal of Translational Medicine
|
March 6, 2026
Novel driver gene MDC1 confers homologous recombination repair deficiency and genomic instability in chemoresistant relapsing ovarian cancer
Michael Diaz, Nicole Gull, Pei-Chen Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 2023
Axicabtagene Ciloleucel in Combination with the 4-1BB Agonist Utomilumab in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Phase 1 Results from ZUMA-11
Michael D Jain, David B Miklos, Caron A Jacobson, et al.
Leukemia
|
August 30, 2024
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma
Jennifer Sun, Stefan Corradini, Feda Azab, et al.
Nature Communications
|
November 28, 2020
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
Cinzia Federico, Kinan Alhallak, Jennifer Sun, et al.
Nature Genetics
|
January 9, 2023
Single-cell transcriptomic analysis of endometriosis
Marcos A S Fonseca, Marcela Haro, Kelly N Wright, et al.
Page
of 7